CAR-T Treatment Continues to Astonish in Rheumatologic Diseases
Numbers of patients, length of follow-up keep growing with no visible downside (yet)
Source: medpagetoday.com
Stay updated with breaking news from Georg Schett. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Numbers of patients, length of follow-up keep growing with no visible downside (yet)
Experts give their top picks and hot tips on data being presented at the upcoming European Congress of Rheumatology taking place on June 12-15 in Vienna, Austria.
Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseases...
Aiming for a best-in-class solution to treat and cure B-cell driven autoimmune diseasesGENEVA, May 22, 2024 (GLOBE NEWSWIRE) -- Antion Biosciences (Antion), a Geneva-based cell and gene therapy company